Skip to main content
DiagnosTear Technologies Inc. logo

DiagnosTear Technologies Inc. — Investor Relations & Filings

Ticker · DTR ISIN · CA25244H1055 LEI · 529900Y0T83PGBNF6A04 CSE Manufacturing
Open in API
Filings indexed 73 across all filing types
Latest filing 2026-04-21 Regulatory Filings
Country CA Canada
Listing CSE DTR

About DiagnosTear Technologies Inc.

https://diagnostear.com/

DiagnosTear Technologies Inc. is an ophthalmic company specializing in advanced, disruptive diagnostic solutions for the management of eye diseases. The company focuses on point-of-care diagnosis of front-of-the-eye pathologies through the analysis of tear fluid composition. Its primary technology platform, TeaRx, facilitates the multi-parameter assessment of conditions such as Dry Eye Syndrome (DES) and Severe Meibomian Gland Dysfunction (MGD). Products like the TeaRx Red Eye diagnostic device are designed for commercial readiness and large-scale manufacturing. TeaRx is positioned as a critical tool for pre- and post-operative assessment in cataract and refractive surgeries, aligning with current ophthalmic guidelines.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 80% confidence The document is a corporate press release announcing a change in the Company’s financial reporting frequency (from quarterly to semi-annual) under a regulatory order (British Columbia Securities Commission CBO 51-933). It does not contain actual financial results, MD&A, or a published interim/annual report, nor does it present earnings, dividends, or other specific filing content. Instead, it is a regulatory announcement about reporting obligations. This fits the “Regulatory Filings” (RNS) category as a general regulatory disclosure that does not neatly fit into other specific filing types.
2026-04-21 English
News release - English.pdf
Regulatory Filings Classification · 78% confidence The document is a press release announcing a change in the company’s financial reporting framework (from quarterly to semi-annual) under Canadian securities rules (CBO 51-933). It does not contain financial statements itself, nor does it announce a specific report publication; rather it is a regulatory announcement regarding disclosure practices. This fits the fallback “Regulatory Filings” category (Code: RNS).
2026-04-21 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a Form of Proxy for DiagnosTear Technologies Inc.’s Annual General Meeting scheduled for May 7, 2026. It solicits management proposals, voting instructions, appointment of proxyholders, and includes voting methods and signature blocks. This falls squarely under materials sent to shareholders to request votes and provide meeting information. Therefore, it is a Proxy Solicitation & Information Statement.
2026-04-17 English
Other.pdf
Regulatory Filings Classification · 78% confidence The document is not the interim or annual financial statements themselves but a shareholder request form to receive those statements by mail or email. It does not announce results, management changes, dividends, or any of the more specific categories. It instead fulfills a regulatory requirement to solicit requests for financial statements, which does not fit any specific filing category. Therefore it defaults to the general “Regulatory Filings” fallback category (RNS).
2026-04-17 English
Other.pdf
Regulatory Filings Classification · 90% confidence The document is a short compliance certification letter from the CFO regarding the mailing of proxy materials under Canadian National Instrument 54-101 ahead of a shareholder meeting. It does not contain proxy solicitation materials themselves, results of votes, or financial statements, nor does it announce a report’s publication. This is a generic regulatory notice, fitting best in the fallback category Regulatory Filings (RNS).
2026-04-17 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a Notice of Annual General Meeting of Shareholders along with the accompanying Information Circular and proxy solicitation materials. It is not a presentation deck, full annual or interim financial report, or simple announcement of a report publication. Instead, it provides detailed meeting and voting information and solicits proxies, which matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-17 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.